Thursday, 29 May 2014

Welcome to the genomics core blog

This is the welcome post for a new venture in the genomics core at the Cancer Research UK Cambridge Institute. This blog will be written by the members of the lab and is likely to focus on new technologies, interesting publications, tweaks to methods and anything else that takes our interest that we think you'll enjoy reading about.

We're writing it for users of our core lab but would be happy to get comments back from anyone that finds the content useful. I've been blogging personally for a couple of years now and have persuaded my group that it is something they will enjoy, and that won't take up too much time. I'll report back in year if it's worked out as we hope it will!

You'll get posts from:
  • James Hadfield - Core Facility Manager
  • Sarah Leigh-Brown - Core Facility Deputy
  • Michelle Pugh - Senior Scientific Officer
  • Hannah Haydon - Scientific Officer
  • Fatimah Bowater - Scientific Officer
  • Rosalind Launchbury - Scientific Officer


  1. In recent decades, with the whole genome sequencing technology continuing to be mature, we also gradually found a lot of clustering and regular interval short palindromic repeat (clustered regularly interspaced short palindromic repeat sequences) in a variety of bacteria and archaea, that CRISPR/Cas9 System sequences.

  2. Lentiviral Vectors ,Chimeric antigen receptor (CAR) T cell therapy is a cellular therapy which redirects a patient’s T cells to specifically target and destroy tumor cells.

  3. TUNEL Apoptosis Assay (Chromogenic) The TUNEL assay relies on the TdT enzyme to catalyze the addition of labeled dUTP to the 3’-hydroxyl (3’-OH) ends of cleaved DNA fragmentations. Labeled dUTP such as biotin-dUTP can be recognized using secondary reagent streptavidin through colorimetric detection.